April 2011

Glaxo's growth is not an accident: Andrew Witty, global CEO

Glaxo's growth is not an accident: Andrew Witty, global CEO

Economic Times, India

Emerging botulinum toxins enter the cosmetic market

Emerging botulinum toxins enter the cosmetic market

Modern Medicine

ICON and ACRONET Sign Alliance Agreement For Clinical Development

ICON and ACRONET Sign Alliance Agreement For Clinical Development

Bioresearch Online

Drug Companies Stocks Underperfoming: JNJ, NVS, PFE

Drug Companies Stocks Underperfoming: JNJ, NVS, PFE

Trader's Huddle

Sellers in Control - Endo Pharmaceuticals

Sellers in Control - Endo Pharmaceuticals

Trader's Huddle

Endo

Merry First-Quarter For Merck As Earnings Triple

Merry First-Quarter For Merck As Earnings Triple

Forbes

Earnings Preview: Pfizer reports on first quarter

Earnings Preview: Pfizer reports on first quarter

Yahoo/AP

Nice Efficacy, Pfizer, But...

Nice Efficacy, Pfizer, But...

Motley Fool

Abbott Receives U.S. FDA Approval for AndroGel® 1.62% to Treat Men with Low Testosterone

Abbott Receives U.S. FDA Approval for AndroGel® 1.62% to Treat Men with Low Testosterone

Yahoo/PR NewsWire

Genentech, Once Known For Innovation, Is Pursuing A Nexium Strategy With Lucentis

Genentech, Once Known For Innovation, Is Pursuing A Nexium Strategy With Lucentis

Forbes